Literature DB >> 13460862

Experience with tolbutamide (orinase in the management of 100 cases of diabetes.

J B McKENDRY, K KUWAYTI, L A SAGLE.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS/effects

Mesh:

Substances:

Year:  1957        PMID: 13460862      PMCID: PMC1824516     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  [A new anti-diabetes principle; results of clinical research].

Authors:  H FRANKE; J FUCHS
Journal:  Dtsch Med Wochenschr       Date:  1955-10-07       Impact factor: 0.628

2.  [An effective peroral anti-diabetic drug (BZ 55)].

Authors:  F BERTRAM; E BENDFELDT; H OTTO
Journal:  Dtsch Med Wochenschr       Date:  1955-10-07       Impact factor: 0.628

3.  [A new blood-sugar reducing substance; preliminary data].

Authors:  J D ACHELIS; K HARDEBECK
Journal:  Dtsch Med Wochenschr       Date:  1955-10-07       Impact factor: 0.628

4.  Fatal hypoglycaemic coma from the use of tolbutamide (orinase).

Authors:  J B MCKENDRY
Journal:  Can Med Assoc J       Date:  1957-04-01       Impact factor: 8.262

5.  Clinical and pharmacological effects of substance BZ-55 in diabetes; (p-aminophenylsulfonyl butylcarbamide).

Authors:  R C ANDERSON; W R KIRTLEY; A S RIDOLFO; M A ROOT
Journal:  Diabetes       Date:  1956 Sep-Oct       Impact factor: 9.461

  5 in total
  4 in total

1.  Clinical experience with DBI (phenformin) in the management of diabetes.

Authors:  J B McKENDRY; K KUWAYTI; P P RADO
Journal:  Can Med Assoc J       Date:  1959-05-15       Impact factor: 8.262

2.  Preliminary observations on management of diabetes with "stabinol".

Authors:  M F HEALY; J D ARNEAUD
Journal:  Br Med J       Date:  1960-09-24

3.  Clinical experience with the oral antidiabetic compound, tolazamide.

Authors:  J B McKendry; K F Gfeller
Journal:  Can Med Assoc J       Date:  1967-03-04       Impact factor: 8.262

4.  A COMPARATIVE STUDY OF SOME BRANDS OF TOLBUTAMIDE AVAILABLE IN CANADA. I. CLINICAL ASPECTS.

Authors:  J B MCKENDRY; F C LU; D BICKERTON; G HANCHARYK
Journal:  Can Med Assoc J       Date:  1965-05-22       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.